Cercar
01/10/2021
Non-muscle-invasive bladder cancer: An overview of potential new treatment options
Shore, ND, Redorta, JP, Robert, G, Hutson, TE, Cesari, R, Hariharan, S, Faba, G, Briganti, A, Steinberg, GD. Non-muscle-invasive bladder cancer: An overview of potential new treatment options. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2021; 39(10)DOI:10.1016/j.urolonc.2021.05.015. PMID:34167873. IF:2.954(Q3/6D).
01/10/2021
Exploratory analysis on the usage of Pi-score algorithm over endoscopic stone treatment step 1 protocol
Veneziano, D, Patruno, G, Talso, M, Tokas, T, Proietti, S, Porreca, A, Kamphuis, G, Biyani, S, Emiliani, E, Cepeda Delgado, M, de Mar Perez, LM, Miano, R, Ferretti, S, Macchione, N, Kallidonis, P, Montanari, E, Tripepi, G, Ploumidis, A, Cacciamani, G, Lima, E, Somani, B. Exploratory analysis on the usage of Pi-score algorithm over endoscopic stone treatment step 1 protocol. Minerva Urology And Nephrology. 2021; 73(5)DOI:10.23736/S2724-6051.20.03747-9. PMID:32748615. IF:5.214(Q1/3D).
01/10/2021
OUTCOMES FOLLOWING SURGICAL MANAGEMENT OF ADRENOCORTICAL CARCINOMA: A SINGLE-CENTER EXPERIENCE
Turco, M, Huguet, J, Territo, A, Fontana, M, Faba, OR, Palou, J, Breda, A. OUTCOMES FOLLOWING SURGICAL MANAGEMENT OF ADRENOCORTICAL CARCINOMA: A SINGLE-CENTER EXPERIENCE. ARCHIVOS ESPANOLES DE UROLOGIA. 2021; 74(8)DOI:10.37554/en-20210206-3424-8. PMID:34605409. IF:0.430(Q4/10D).
29/09/2021
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
Alcaraz, A, Rodriguez-Antolin, A, Carballido-Rodriguez, J, Castro-Diaz, D, Medina-Polo, J, Fernandez-Gomez, JM, Ficarra, V, Palou, J, Roca, JPD, Angulo, JC, Esteban-Fuertes, M, Cozar-Olmo, JM, Perez-Leon, N, Molero-Garcia, JM, Ledesma, AFP, Brenes-Bermudez, FJ, Manasanch, J. Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-98586-5. PMID:34588509. IF:4.997(Q2/3D).
01/09/2021
Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical Cystectomy
Canto, E, Faba, OR, Zamora, C, Mulet, M, Garcia-Cuerva, MS, Palomino, A, Anguera, G, Breda, A, Maroto, P, Vidal, S. Immunological Status of Bladder Cancer Patients Based on Urine Leukocyte Composition at Radical Cystectomy. Biomedicines. 2021; 9(9)DOI:10.3390/biomedicines9091125. PMID:34572311. IF:4.757(Q2/4D).
01/09/2021
Development Methodology of the Novel Endoscopic Stone Treatment Step 2/A Training/Assessment Curriculum and a Roadmap on Developing Hands-on Training Curriculums in Future: An International Collaborative Work by European Association of Urology Sections
Veneziano, D, Ploumidis, A, Cleynenbreugel, B, Gozen, A, Palou, J, Sarica, K, Liatsikos, E, Miano, R, Ahmed, K, Kamphuis, G, Tokas, T, Somani, BK, ESU Training Grp. Development Methodology of the Novel Endoscopic Stone Treatment Step 2/A Training/Assessment Curriculum and a Roadmap on Developing Hands-on Training Curriculums in Future: An International Collaborative Work by European Association of Urology Sections. JOURNAL OF ENDOUROLOGY. 2021; 35(9)DOI:10.1089/end.2021.0040. PMID:34006138. IF:2.619(Q3/7D).